Finally, we performed immune infiltration, immune checkpoint and other related functional analysis of four genes (TTN, ARID1A, KDM6A, RB1) that were highly mutated in the high-risk group, and the findings showed that the four genes were significantly relevant to immunity in BLCA. The gene discussed is KDM6A; the disease is bladder transitional cell carcinoma.